RYACTLA
Live / Applied — Fourth extension granted (statement of use) (as of 14 Jan 2026)
What this means for you
Not registered yet, but its 14 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97795124
- Mark type
- Stylized text
- Filed
- 14 Feb 2023
- Published for opposition
- 19 Dec 2023
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for treatment of cancer
Owner
- BIONTECH SE, Mainz, DE
- OncoC4, Inc., Rockville, MD, US
- OncoC4, Inc., Rockville, MD, US
Prosecution history
- 15 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jan 2026 — SOU EXTENSION 4 GRANTED
- 14 Jan 2026 — SOU EXTENSION 4 FILED
- 14 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2025 — SOU EXTENSION 3 GRANTED
- 12 Aug 2025 — SOU EXTENSION 3 FILED
- 12 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Feb 2025 — SOU EXTENSION 2 GRANTED
- 11 Feb 2025 — SOU EXTENSION 2 FILED
- 11 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jun 2024 — SOU EXTENSION 1 GRANTED
- 26 Jun 2024 — SOU EXTENSION 1 FILED